Weiss Multi-Strategy Advisers’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-503,476
| Closed | -$5.26M | – | 394 |
|
|
2023
Q4 | $5.26M | Buy |
503,476
+127,127
| +34% | +$1.33M | 0.13% | 196 |
|
|
2023
Q3 | $3.84M | Buy |
376,349
+42,412
| +13% | +$433K | 0.09% | 270 |
|
|
2023
Q2 | $2.52M | Buy |
333,937
+163,639
| +96% | +$1.23M | 0.05% | 402 |
|
|
2023
Q1 | $1.51M | Sell |
170,298
-238,468
| -58% | -$2.11M | 0.04% | 435 |
|
|
2022
Q4 | $3.73M | Buy |
408,766
+157,236
| +63% | +$1.43M | 0.11% | 269 |
|
|
2022
Q3 | $2.03M | Sell |
251,530
-49,525
| -16% | -$400K | 0.05% | 389 |
|
|
2022
Q2 | $2.26M | Buy |
301,055
+259,255
| +620% | +$1.95M | 0.07% | 355 |
|
|
2022
Q1 | $393K | Buy |
+41,800
| New | +$393K | 0.01% | 556 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 553 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 541 |
|
|
2016
Q4 | – | Sell |
-7,500
| Closed | -$345K | – | 450 |
|
|
2016
Q3 | $345K | Buy |
7,500
+210
| +3% | +$9.66K | 0.02% | 303 |
|
|
2016
Q2 | $366K | Sell |
7,290
-3,210
| -31% | -$161K | 0.03% | 304 |
|
|
2016
Q1 | $562K | Sell |
10,500
-400
| -4% | -$21.4K | 0.02% | 332 |
|
|
2015
Q4 | $715K | Sell |
10,900
-200
| -2% | -$13.1K | 0.05% | 238 |
|
|
2015
Q3 | $627K | Sell |
11,100
-68,900
| -86% | -$3.89M | 0.03% | 257 |
|
|
2015
Q2 | $4.73M | Sell |
80,000
-25,000
| -24% | -$1.48M | 0.19% | 128 |
|
|
2015
Q1 | $6.54M | Sell |
105,000
-20,000
| -16% | -$1.25M | 0.29% | 92 |
|
|
2014
Q4 | $7.19M | Sell |
125,000
-15,000
| -11% | -$863K | 0.25% | 81 |
|
|
2014
Q3 | $7.53M | Hold |
140,000
| – | – | 0.18% | 123 |
|
|
2014
Q2 | $7.34M | Hold |
140,000
| – | – | 0.16% | 121 |
|
|
2014
Q1 | $7.4M | Buy |
140,000
+5,000
| +4% | +$264K | 0.15% | 147 |
|
|
2013
Q4 | $5.41M | Buy |
135,000
+45,000
| +50% | +$1.8M | 0.12% | 199 |
|
|
2013
Q3 | $3.4M | Buy |
90,000
+20,000
| +29% | +$756K | 0.07% | 247 |
|
|
2013
Q2 | $2.74M | Buy |
+70,000
| New | +$2.74M | 0.08% | 268 |
|